Montelukast Prescribing at PARK HOUSE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
269
Total Quantity
6,146
NHS Cost
£303
vs National Avg
-60.7%
PARK HOUSE prescribed 269 items of Montelukast over the last 12 months at a cost of £303 to the NHS. This is 60.7% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
21
Jul 2026
18
Jul 2026
19
Jul 2026
27
Jul 2026
21
Jul 2026
28
Jul 2026
19
Jul 2026
26
Jul 2026
24
Jul 2026
19
Jul 2026
22
Jul 2026
25
Prescribing Details
| Total Items | 269 |
|---|---|
| Total Quantity | 6,146 |
| Total NHS Cost | £303 |
| Presentations | 3 different forms |
| vs National Average | -60.7% |
Montelukast Prescribing Comparison
| This practice | 269 items |
|---|---|
| National average per practice | 685 items |
| Difference | -60.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.